Article
Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
Medical microbiology and immunology - 1 Aug 2011
Bleymehl Karoline, Cinatl Jindrich, Schmidt-Chanasit Jonas
Abstract excerpt
The treatment of varicella-zoster virus (VZV) reactivation is based on nucleoside analogues acyclovir (ACV) and bromevinyldeoxyuridine (BVdU) and a phosphonic acid derivative (PFA). Drug-resistant mutants of 3 wild-type (WT) VZV strains were obtained by exposure of human retinal pigment epithelial (hRPE) cells inoculated with cell-free WT virus at increasing concentrations of ACV, BVdU, and PFA. In addition to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
